Rave Lite

Not every clinical trial requires a full-scale EDC implementation. Early-phase and post-market studies often need to move fast, operate lean, and control costs without compromising data quality or compliance.


Rave Lite is a simplified, cost-effective offering of
Medidata Rave EDC designed for Phase I, Phase IV, feasibility, and post-market studies. It delivers essential data capture and management capabilities through a pre-configured approach.

Download Overview
 

Launch Faster. Stay Flexible.

When timelines are tight and resources are lean, complexity slows everything down. Study teams need a way to move forward without overbuilding. 

Rave Lite removes the friction so you can focus on running your studies, not managing the platform.

Pay Only for What You Need
Affordable Scalability, Superior Functionality
Streamlined Study Build

Built for Different Study Needs

Phase I Studies

Phase I Studies

Launch first-in-human studies quickly and confidently. 

Rave Lite helps Phase I teams move from build to enrollment faster, with streamlined setup and essential data capture that keeps studies on schedule without unnecessary complexity.

Read Fact Sheet

More Resources


Explore deeper guidance and related materials.

View All Resources

FAQ

Rave Lite is specifically tailored for Phase I, Phase IV, and medical device feasibility and post-market studies. It is designed to support the specific data capture, management, and analysis needs of these early and late-stage trials with a focused set of capabilities.

Yes. Rave Lite is a focused offering of Rave EDC, allowing users to leverage the same robust, trusted technology and superior functionality as the standard platform. It ensures data security and management quality while being "right-sized" for specific study requirements.

Yes. The solution features an adaptable pricing structure that allows sponsors to pay only for what’s needed. This cost-effective model scales according to the study's needs, helping to reduce unnecessary complexities and costs for smaller or focused trials.

Yes. Rave Lite streamlines the study build process through pre-configured, pre-validated, and accelerated implementation capabilities. This approach ensures efficient study builds that help keep trials on schedule.

Yes. Medidata offers a variety of training options for our clients and partners, including both self-paced and instructor-led courses. To learn more about available courses and to access our resources, please visit the Medidata Global Education and Training section.